SLP

Simulations Plus, Inc. | Healthcare

-0.45825%

Analisi Pre-Earnings (Antonio AI)

2025-12-18
Sentiment
80.0/100
Salute

Caution

Verdict

The street is clearly euphoric about SLP, chasing momentum and a nice FDA story. 🔥 But without seeing the balance sheet, this could be a polished turd. I'm on the sidelines until I can run the numbers. ⚠️

Catalysts
  • Strong price momentum and bullish media coverage creating a pre-earnings run-up.
  • Positioned to benefit from new FDA guidance, creating a strong narrative.
  • Recent earnings met estimates, providing a floor for expectations.
Rischi
  • Unknown financial health is a deal-breaker. A weak balance sheet or poor cash flow could sink the stock post-earnings, regardless of sentiment.
Approfondisci con Antonio
Valutazione
P/E (TTM)-5.814863911130804
Forward P/E-5.814863911130804
P/S4.578594777502706
Market Cap393826226
Finanze & Debito
CashNone
DebtNone
Debt/Equity0.005808739770074084
Current Ratio5.110551771789557
Redditività
ROE-0.37148193923753736
Profit Margin-0.7861612530012565
Operating Margin-0.902417177761467
Rev. Growth0.17516826963425483
Ultime News (Context per AI)